Despite its initial treatment as a nuisance variable, the placebo effect is now recognized as
a powerful determinant of health across many different diseases and encounters. This is in …

Duchenne muscular dystrophy (DMD) is a fatal X-linked degenerative muscle disease
caused by the absence of the microtubule-associated protein dystrophin, which results in a …

Chemotherapy-induced peripheral neuropathy (CIPN), a dose-limiting neurotoxic effect of
chemotherapy, is the most common reason for early cessation of cancer treatment. This can …

Our objective was to describe the racial and ethnic differences in experimental pain sensitivity.
Four databases (PubMed, EMBASE, the Cochrane Central Register of Controlled Trials, …

MicroRNAs (miRs) are small noncoding RNAs that negatively regulate gene expression at
the post-transcriptional level. To identify miRs that may regulate neuronal cell death after …

Pathological or in vitro overexpression of the truncated TrkB (TrkB.T1) receptor inhibits
signaling through the full-length TrkB (TrkB.FL) tyrosine kinase receptor. However, to date, the …

Background: A major clinical issue affecting 10-40% of cancer patients treated with oxaliplatin
is severe peripheral neuropathy with symptoms including cold sensitivity and neuropathic …

Although recent scientific advances have improved our understanding of basic biological
mechanisms underlying chemotherapy-induced peripheral neuropathy (CIPN), few …

Quantitative sensory testing can be used to assess peripheral and central sensitization;
important factors that contribute to the individual’s experience of pain and disability. Many …

Imbalances in neurotrophins or their high-affinity Trk receptors have long been reported in
neurodegenerative diseases. However, a molecular link between these gene products and …